Inflammatory Breast Cancer—Comparing the Effectivity of Preoperative Docetaxel-Epirubicine Protocol to Conventional Antracycline-Containing Chemotherapy to Achieve Clinical Benefit and Complete Pathological Response

By Horváth Zsolt  

Pathology & Oncology Research, Vol. 17, Iss. 3, 2011-09 ,pp. : 541-550

Springer Publishing Company

Access to resources Recommend Favorite

Pathologic complete response may not represent the optimal surrogate for survival after preoperative therapy for esophageal cancer

By Blackstock A.  

International Journal of Gastrointestinal Cancer, Vol. 37, Iss. 1, 2006-02 ,pp. : 7-14

Humana Press, Inc

Access to resources Recommend Favorite

A Pathologic Complete Response of Rectal Cancer to Preoperative Combined-Modality Therapy Results in Improved Oncological Outcome Compared With Those Who Achieve No Downstaging on the Basis of Preoperative Endorectal Ultrasonography

By Stipa Francesco   Chessin David   Shia Jinru   Paty Philip   Weiser Martin   Temple Larissa   Minsky Bruce   Wong W.   Guillem Jose  

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1047-1053

Springer Publishing Company

Access to resources Recommend Favorite

ERBB2 overexpression in breast carcinomas - no positive correlation with complete pathological response to preoperative high-dose anthracycline-based chemotherapy

By Vincent-Salomon A.   Carton M.   Freneaux P.   Palangie T.   Beuzeboc P.   Mouret E.   de Cremoux P.   Coue O.   Zafrani B.   Nicolas A.   Clough K.   Fourquet A.   Pouillart P.   Sastre-Garau X.  

European Journal of Cancer, Vol. 36, Iss. 5, 2000-03 ,pp. : 586-591

Elsevier

Access to resources Recommend Favorite

Comparison among different classification systems regarding the pathological response of preoperative chemotherapy in relation to the long-term outcome

By Shien Tadahiko  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 307-313

Springer Publishing Company

Access to resources Recommend Favorite